Cargando…
Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged since December 2019 in Wuhan city, and has quickly spread throughout China and other countries. To date, no specific treatment has been proven to be effective for SARS-CoV-2 infection. According to World Health Organization...
Autores principales: | Hong, Xiaoyang, Xiong, Jing, Feng, Zhichun, Shi, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195062/ https://www.ncbi.nlm.nih.gov/pubmed/32251794 http://dx.doi.org/10.1016/j.ijid.2020.03.058 |
Ejemplares similares
-
Anticoagulation on extracorporeal membrane oxygenation (ECMO)
por: Khilnani, Praveen
Publicado: (2017) -
Imaging adults on extracorporeal membrane oxygenation (ECMO)
por: Lee, Steven, et al.
Publicado: (2014) -
Extracorporeal Membrane Oxygenation (ECMO) and the Critical Cardiac Patient
por: Baran, David A.
Publicado: (2017) -
Extracorporeal Membrane Oxygenation (ECMO) for Refractory Cardiac Arrest
por: Hanneken, Kevin, et al.
Publicado: (2020) -
Modification strategies to improve the membrane hemocompatibility in extracorporeal membrane oxygenator (ECMO)
por: He, Ting, et al.
Publicado: (2021)